Skip to content
Biodatica
Start free

CellSight Technologies, Inc.

Stanford, California

OncologyPhase II
Compare Sign in to watch

What changed

Phase II trial registered: Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

2mo agoTrial registeredMay 4, 2026Source filing (opens the source filing in a new tab)

Momentum

72no change

Momentum 72 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,843 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Mar 1, 2022

    Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit · TERMINATED · sponsor: CellSight Technologies, Inc. · A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

    ClinicalTrials.gov · NCT04260256 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Feb 4, 2019

    Cigarette Smoker, Current Smoker, Former Smoker, Multiple Pulmonary Nodules, Pulmonary Nodule · COMPLETED · sponsor: Andrei Iagaru · 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

    ClinicalTrials.gov · NCT03824535 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Mar 13, 2017

    Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma · ACTIVE_NOT_RECRUITING · sponsor: National Cancer Institute (NCI) · Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

    ClinicalTrials.gov · NCT04439227 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources